4.4 Article

The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Efficacy of endoscopic ultrasound in characterizing mass lesions in chronic pancreatitis

Jayaprakash Sreenarasimhaiah

JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)

Article Gastroenterology & Hepatology

Type 2 diabetes mellitus and CA 19-9 levels

Oya Uygur-Bayramicli et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2007)

Article Oncology

Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice

DV Mann et al.

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)

Article Gastroenterology & Hepatology

EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma

HR Mertz et al.

GASTROINTESTINAL ENDOSCOPY (2000)